Recent Finacing
Recent Raise
NeOnc Technologies is a clinical-stage biotech developing the NEO platform of intranasal drug formulations and delivery methods (NEO100, NEO212) to enhance blood–brain barrier penetration for CNS and brain tumor therapies.